Could a blood filter sweep out hidden plastic pollution?
NCT ID NCT07658443
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This study investigates whether a medical procedure called double-filtration plasmapheresis (DFPP) can reduce the amount of tiny plastic particles circulating in human blood. Twenty adults who are already scheduled to receive DFPP for other medical reasons will provide blood samples before and after treatment. Researchers will measure changes in microplastic and nanoplastic levels using advanced lab techniques. The goal is to see if this filtering method can effectively remove plastic particles from the bloodstream.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Double-filtration plasmapheresis (DFPP) using the IN300 Inuspheresis device
- What this could lead to
- If successful, this could show that plasmapheresis reduces plastic particle levels in blood, potentially pointing toward a method to lower body plastic burden.
- What could go wrong
- This is a small, early observational study with only 20 participants. It measures short-term changes, not long-term health effects, and may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOUBLE-FILTRATION PLASMAPHERESIS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ayus Medical Basel AG
Basel, 4051, Switzerland
-
Ayus Medical Buergenstock - Buergenstock Resort Lake Lucerne
Obergünzburg, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.